| PP-1 |
OUTCOMES IN PATIENTS OF PRIMARY AMYLOIDOSIS WITH CARDIAC INVOLVEMENT TREARTED WITH DARATUMUMAB BASED QUADRUPLET THERAPY : A TERTIARY CENTRE STUDY |
AMYLOIDOSIS |
| PP-2 |
RETROSPECTIVE ANALYSIS OF PATIENTS OF MULTIPLE MYELOMA ASSOCIATED WITH AL - AMYLOIDOSIS |
AMYLOIDOSIS |
| PP-3 |
AN INTERESTING CASE OF AL AMYLOIDOSIS DUE TO PLASMA CELL DYSCRASIA |
AMYLOIDOSIS |
| PP-4 |
CARDIAC AMYLOIDOSIS ? A TALE OF DIAGNOSTIC ODYSSEY! |
AMYLOIDOSIS |
| PP-5 |
PROSPECTIVE STUDY TO ASCERTAIN THE EARLY RESPONSE OF FREE LIGHT CHAINS WHEN LOW DOSE DARATUMUMAB ADDED TO STANDARD CARE IN A RESOURCE LIMITED SETTING : |
AMYLOIDOSIS |
| PP-6 |
UNVEILING THE UNCOMMON: B-ALL EMERGING IN A LANDSCAPE OF MULTIPLE MYELOMA ? A CASE REPORT. |
CLINICAL |
| PP-7 |
BARRIERS TO AUTOLOGOUS STEM CELL TRANSPLANT IN TRANSPLANT ELIGIBLE MULTIPLE MYELOMA PATIENTS ? A PUBLIC SECTOR EXPERIENCE |
CLINICAL |
| PP-8 |
CLINICO-PATHOLOGICAL PROFILE OF RELAPSED MULTIPLE MYELOMA : A SINGLE CENTER STUDY FROM NEPAL |
CLINICAL |
| PP-9 |
BREACHING BOUNDARIES (BEYOND THE BONES) |
CLINICAL |
| PP-10 |
THE EXPERIENCE OF HEMATOPOIETIC STEM CELL TRANSPLANTATION /BMT FROM TERTIARY CENTRE IN BIHAR. |
CLINICAL |
| PP-11 |
UNCONVENTIONAL ONSET OF MULTIPLE MYELOMA IN YOUNG PATIENT |
CLINICAL |
| PP-12 |
OUTCOMES OF AUTOLOGOUS STEM CELL TRANSPLANTATION IN MULTIPLE MYELOMA PATIENTS WITH UNDERLYING CHRONIC RENAL FAILURE IN A TERTIARY CARE ONCOLOGY CENTRE IN EASTERN INDIA |
CLINICAL |
| PP-13 |
ALLOGENEIC STEM CELL TRANSPLANTATION IN MULTIPLE MYELOMA: A CASE REPORT |
CLINICAL |
| PP-14 |
QUALITY OF LIFE IN MULTIPLE MYELOMA PATIENTS ON HOME OR OUTPATIENT BASED THERAPY: A CROSS-SECTIONAL PILOT STUDY |
CLINICAL |
| PP-15 |
CASE SERIES OF EXTRAMEDULLARY MYELOMA |
CLINICAL |
| PP-16 |
SOLITARY PLASMACYTOMA ? A SLOW PROGRESSOR OR NOT; A CASE SERIES |
CLINICAL |
| PP-17 |
TECLISTAMAB IN PENTAREFRACTORY MULTIPLE MYELOMA : 2 CASES, DIFFERENT OUTCOMES |
CLINICAL |
| PP-18 |
CARE PATTERN OF MULTIPLE MYELOMA |
CLINICAL |
| PP-19 |
A CASE REPORT AND EXPERIENCE OF TECLISTAMAB IN AN ELDERLY PATIENT WITH REFRACTORY MULTIPLE MYELOMA |
CLINICAL |
| PP-20 |
DECADE EXPERIENCE OF LIGHT CHAIN MULTIPLE MYELOMA IN YOUNG ADULTS: A COMPARATIVE ANALYSIS |
CLINICAL |
| PP-21 |
FOCUS ON THALASSEMIA RELATED ANEMIA IN A CASE OF RELAPSED MULTIPLE MYE |
CLINICAL |
| PP-22 |
RARE COMPLICATION-ACUTE ESOPHAGEAL NECROSIS (BLACK ESOPHAGUS) IN TWO CASES OF MULTIPLE MYELOMA. |
CLINICAL |
| PP-23 |
MULTIPLE MYELOMA WITH PLASMACYTOMA OF SKULL BONE WITH INTRACRANIAL EXTENSION MIMICKING METASTATIC THYROID MALIGNANCY: CASE REPORT |
CLINICAL |
| PP-24 |
REAL WORLD DATA OF AUTO BMT IN MULTIPLE MYELOMA : A SINGLE INSTITUTION EXPERIENCE |
CLINICAL |
| PP-25 |
CNS INVOLVEMENT IN MULTIPLE MYELOMA |
CLINICAL |
| PP-26 |
CHALLENGES IN TREATING MULTIPLE MYELOMA IN RESOURCE POOR SETTING: A REAL WORD EXPERIENCE |
CLINICAL |
| PP-27 |
IMPROVED TOLERABILITY AND OUTCOMES WITH NOVEL MELPHALAN ADMINISTRATION TECHNIQUE IN AUTOLOGOUS STEM CELL TRANSPLANTATION (ASCT) FOR MULTIPLE MYELOMA |
CLINICAL- MM |
| PP-28 |
AUTOLOGOUS STEM CELL TRANSPLANT FOR PLASMA CELL DYSCRASIAS: A SINGLE CENTER EXPERIENCE FROM NORTHEN INDIA. |
CLINICAL- MM |
| PP-29 |
TIME TO AUTOLOGOUS STEM CELL TRANSPLANT IN MULTIPLE MYELOMA PATIENTS: A REAL-WORLD EXPERIENCE FROM A TERTIARY CANCER CENTRE IN RURAL INDIA |
CLINICAL- MM |
| PP-30 |
HIGH RATES OF RENAL IMPAIRMENT AND SUBOPTIMAL OVERALL SURVIVAL IN PATIENTS WITH INVOLVED FREE LIGHT CHAINS EXCEEDING 1000 MG/L AT BASELINE IN MULTIPLE MYELOMA |
CLINICAL-MM |
| PP-31 |
BORTEZOMIB , LENALIDOMIDE AND DEXAMETHASONE (VRD) VERSUS BORTEZOMIB, THALIDOMIDE AND DEXAMETHASONE (VTD) FOR NEWLY DIAGNOSED MULTIPLE MYELOMA ? A RANDOMIZED ST |
CLINICAL-MM |
| PP-32 |
A PILOT STUDY TO ANALYSE BONE HEALTH IN MULTIPLE MYELOMA PATIENTS USING RADIOLOGICAL AND BIOCHEMICAL MARKERS OF BONE METABOLISM AT A TERTIARY CARE CENTRE |
CLINICAL-MM |
| PP-33 |
PATIENT CHARACTERISTICS, TREATMENT REGIMENS AND SURVIVAL OUTCOMES OF NEWLY DIAGNOSED MULTIPLE MYELOMA PATIENTS IN SOUTH INDIA: A SINGLE CENTRE EXPERIENCE |
CLINICAL-MM |
| PP-34 |
AUTOLOGOUS STEM CELL TRANSPLANT IN MULTIPLE MELOMA- EXPERIENCE FROM TERTIARY CENTRE IN SOUTH INDIA |
CLINICAL-MM |
| PP-35 |
EVALUATION OF MEASURABLE RESIDUAL DISEASE BY HIGH SENSITIVE MULTICOLOR FLOWCYTOMETRY IN A NEWLY DIAGNOSED MULTIPLE MYELOMA IN A TERTIARY CARE CENTER. |
CLINICAL-MM |
| PP-36 |
REAL-WORLD OUTCOMES OF SUBCUTANEOUS DARATUMUMAB: A POOLED ANALYSIS FROM MULTICENTRE EXPERIENCE IN EASTERN INDIA |
CLINICAL-MM |
| PP-37 |
FACTORS AFFECTING LONG-TERM DISEASE-FREE REMISSION IN PATIENTS OF MULTIPLE MYELOMA UNDERGOING SINGLE AUTOLOGOUS STEM CELL TRANSPLANT |
CLINICAL-MM |
| PP-38 |
LOW DOSE DARATUMUMAB IN HIGH-RISK MYELOMA |
CLINICAL-MM |
| PP-39 |
EVALUATING THE IMPACT OF NAC ON MUCOSITIS IN MULTIPLE MYELOMA PATIENTS UNDERGOING BONE MARROW TRANSPLANTATION |
CLINICAL-MM |
| PP-40 |
CLINICAL OUTCOMES OF MULTIPLE MYELOMA POST AUTOLOGOUS HEMATOPOIETIC CELL TRANSPLANT: A SINGLE CENTRE STUDY. |
CLINICAL-MM |
| PP-41 |
CARFILZOMIB-BASED TRIPLET REGIMENS FOR FIRST-LINE & SECOND-LINE THERAPY OF MULTIPLE MYELOMA: SINGLE-CENTER EXPERIENCE FROM NORTH INDIA |
CLINICAL-MM |
| PP-42 |
INFECTIONS IN NEWLY DIAGNOSED MULTIPLE MYELOMA PATIENTS IN A TERTIARY HEALTHCARE CENTRE IN WESTERN INDIA |
CLINICAL-MM |
| PP-43 |
A RETROSPECTIVE COHORT STUDY TO ASSESS?THE BENEFIT OF HIGH-DOSE CHEMOTHERAPY WITH AUTOLOGOUS STEM CELL RESCUE IN PATIENTS WITH TRANSPLANT-ELIGIBLE MULTIPLE MYELOMA? |
CLINICAL-MM |
| PP-44 |
HEALTH RELATED QUALITY OF LIFE (HRQOL) IN PATIENTS OF MULTIPLE MYELOMA |
CLINICAL-MM |
| PP-45 |
DURATION OF REMISSION IN MULTIPLE MYELOMA PATIENTS AFTER AUTOLOGOUS HEMATOPOIETIC STEM CELL TRANSPLANT: EXPERIENCE FROM A SINGLE CENTER STUDY IN WEST BENGAL |
CLINICAL-MM |
| PP-46 |
A RETROSPECTIVE COHORT STUDY TO ASSESS?THE BENEFIT OF HIGH-DOSE CHEMOTHERAPY WITH AUTOLOGOUS STEM CELL RESCUE IN PATIENTS WITH TRANSPLANT-ELIGIBLE MULTIPLE MYELOMA? |
CLINICAL-MM |
| PP-47 |
OUTCOMES OF AUTOLOGOUS HSCT IN PATIENTS OF MULTIPLE MYELOMA: ( A RETROSPECTIVE ANALYSIS) OF 23 YEARS AT A SINGLE TERTIARY CARE CENTER |
CLINICAL-MM |
| PP-48 |
THE ROLE OF 68GA-PENTIXAFOR PET/CT IMAGING IN MULTIPLE MYELOMA |
DIAGNOSTIC- RADIOLOGY |
| PP-49 |
UTILITY OF 68GA-PENTIXAFOR PET/CT FOR MINIMAL RESIDUAL DISEASE DETECTION IN MULTIPLE MYELOMA: A PILOT STUDY |
DIAGNOSTIC- RADIOLOGY |
| PP-50 |
A COMPARATIVE STUDY ON PLATELET FUNCTION IN NEWLY DIAGNOSED CASES OF MULTIPLE MYELOMA WITH VERSUS WITHOUT RENAL DYSFUNCTION |
LABORATORY |
| PP-51 |
A COMPREHENSIVE ANALYSIS OF FLOW CYTOMETRY MARKERS, CYTOGENETICS, AND CLINICO-PATHOLOGICAL CHARACTERISTICS IN PLASMA CELL NEOPLASMS: INSIGHTS FROM A NORTH INDIAN CENTER |
LABORATORY |
| PP-52 |
A CASE OF MONOCLONAL GAMMOPATHY OF RENAL SIGNIFICANCE PRESENTING AS FANCONI SYNDROME |
NEPHROLOGICAL |
| PP-53 |
IS THERE ANY ROLE OF PET/CT IN THE DIAGNOSIS AND EVALUATION OF MONOCLONAL GAMMOPATHY OF RENAL SIGNIFICANCE? |
NEPHROLOGICAL |
| PP-54 |
MGRS ? WHEN MGUS IS NEITHER UNDETERMINED NOR INSIGNIFICANT! |
NEPHROLOGICAL |
| PP-55 |
INVESTIGATING THE NEUROTOXIC EFFECTS OF TECLISTAMAB: A CASE REVIEW |
NEUROLOGICAL |
| PP-56 |
IDENTIFICATION OF NOVEL BIOMARKERS IN BONE MARROW MESENCHYMAL STROMAL CELLS OF MULTIPLE MYELOMA PATIENTS WITH POOR THERAPEUTIC RESPONSE |
PATHOLOGICAL |
| PP-57 |
MYELOMA PATIENTS WITH NORMAL SFLC RATIO, AT DIAGNOSIS, ARE ENRICHED WITH NON-HIGH- RISK FEATURES IN COMPARISON TO THOSE WITH AN ABNORMAL SFLC RATIO |
PATHOLOGICAL |
| PP-58 |
UNUSUAL OCCURRENCE OF MYELOMATOUS PLEURAL EFFUSION IN EXTRAMEDULLARY RELAPSED MULTIPLE MYELOMA: A CASE REPORT |
PATHOLOGICAL |
| PP-59 |
IMMUNOPHENOTYPING PROFILE AND MEASURABLE RESIDUAL DISEASE MONITORING IN MULTIPLE MYELOMA - AN EXPERIENCE FROM A TERTIARY CARE CENTRE IN SOUTHERN INDIA |
PATHOLOGICAL |
| PP-60 |
CLINICO-HAEMATOLOGICAL PROFILE OF MULTIPLE MYELOMA IN A NORTH INDIAN TERTIARY CARE HOSPITAL |
PATHOLOGICAL |
| PP-61 |
IMMUNE CELL DYSREGULATION ACROSS DISEASE STAGES IN MULTIPLE MYELOMA |
PATHOLOGYICAL- IMMUNOLOGY
|
| PP-62 |
THE CRITICAL ROLE OF THE VARIABLE DOMAIN IN DRIVING PROTEOTOXICITY AND AGGREGATION IN FULL-LENGTH LIGHT CHAINS |
PCD- AMYLOIDOSIS |
| PP-63 |
A RETROSPECTIVE ANALYSIS OF PRIMARY AL-AMYLOIDOSIS IN A TERTIARY CARE CANCER CENTER IN INDIA |
PCD- AMYLOIDOSIS |
| PP-64 |
CLINICAL PROFILE AND TREATMENT OUTCOMES IN PRIMARY AL AMYLOIDOSIS: A SINGLE CENTRE EXPERIENCE FROM NORTH INDIA. |
PCD-AMYLOIDOSIS |
| PP-65 |
CARDIAC AMYLOIDOSIS IN INDIAN PATIENTS: DELAYED DIAGNOSIS AND ADVERSE SURVIVAL |
PCD- AMYLOIDOSIS |
| PP-66 |
IMPACT OF POMALIDOMIDE AND DEXAMETHASONE ON QUALITY OF LIFE IN MGUS ASSOCIATED NEUROPATHY: A CLINICAL ANALYSIS |
PCD- MGUS |
| PP-67 |
WALDENSTROM?S MACROGLOBULINEMIA: CLINICAL PRESENTATION & TREATMENT OUTCOME FROM A TERTIARY CARE CENTRE FROM INDIA |
PCD-WALDENSTROMSMACROGLOBULINEMIA, POEMS |
| PP-68 |
CLINICOPATHOLOGICAL PROFILE AND TREATMENT OUTCOMES IN NEWLY DIAGNOSED WALDENSTROM MACROGLOBULINEMIA : A SINGLE CENTRE RETROSPECTIVE STUDY |
PCD-WALDENSTROMSMACROGLOBULINEMIA, POEMS |
| PP-69 |
ALLOGENIC HEMATOPOETIC CELL TRANSPLANT; THE ULTIMATE SAVIOUR IN PLASMA CELL LEUKEMIA |
PLASMA CELL LEUKAEMIA |
| PP-70 |
HE DIAGNOSTIC ENIGMA OF POEMS SYNDROME CASE SERIES FROM A SINGLE CENTRE. |
WALDENSTROMSMACROGLOBULINEMIA, POEMS |
| PP-71 |
SCLEROMYXEDEMA AND LOCALIZED SCLERODERMA IN PLASMA CELL NEOPLASMS: A SERIES OF DIVERSE PRESENTATIONS |
WALDENSTROMSMACROGLOBULINEMIA, POEMS |
